UCP2 and ovarian carcinoma: UCP2 and UCP3 protein expression increased during ovarian cancer progression and after aggregation in comparison to the MOSE-E with a significant increase in UCP3 for the adherent MOSE-L and MOSE-LTICv spheroids (p<0.05).